ribociclib AS A 3RD LINE THERAPY: A CASE REPORT OF THE PARTIAL RESPONSE (16+ MONTHS DURATION) OF THE METASTATIC HORMONe-SENSITIVE HER2-NEGATIVE BREAST CARCINOMA
О.А. Pavlikova1,2, D.V. Pasynkov1,2,4, L.Kh. Mukhamatgaleeva1,2, O.O. Pasynkova2, I.V. Klyushkin3, A.L. Fedorov2 1Oncology Dispensary of Mari El Republic, Yoshkar-Ola 2Mari State University, Yoshkar-Ola 3Kazan State Medical University, Kazan 4Kazan State Medical Academy ― Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan Pavlikova Оlga А. — Cand. of Sci. (Med.), oncologist of the department … Читать далее